Hypertension (HTN) in patients (pts) treated with ibrutinib (IBR) for chronic lymphocytic leukemia (CLL) Meeting Abstract


Authors: Sarraf Yazdy, M.; Roeker, L.; Gashonia, L.; Goodfriend, J.; Narkhede, M.; Rhodes, J.; Kennard, K.; Morse, H.; Dorsey, C.; Battiato, K.; Deonarine, I.; Carver, J.; Schuster, S. J.; Cheson, B. D.; Mato, A.
Abstract Title: Hypertension (HTN) in patients (pts) treated with ibrutinib (IBR) for chronic lymphocytic leukemia (CLL)
Meeting Title: 15th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 37
Issue: Suppl. 2
Meeting Dates: 2019 Jun 18-22
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2019-06-01
Start Page: 212
End Page: 213
Language: English
ACCESSION: 136932679
DOI: 10.1002/hon.28_2630
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 31187525
DOI/URL:
Notes: Meeting Abstract: 164 -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato
  2. Lindsey Elizabeth Roeker
    132 Roeker
  3. Colleen Dorsey
    16 Dorsey
  4. Hannah Morse
    3 Morse